Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

March 31, 2020

Study Completion Date

September 1, 2021

Conditions
Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

Cardiac Perfusion Rest/Stress Digital PET/CT

"Patients with coronary artery disease undergo a N-13 ammonia rest/stress PET/CT scan.~These patients are given:~1. One 5-10 mCI N13-ammonia (13N-NH3) intravenously and undergo a rest digital PET/CT scan of \~20 minute duration.~2. A dose of 0.4 mg regadenoson (Lexiscan) intravenously over 10 seconds to increase blood flow to the heart~3. One 5-10 mCi N13-ammonia (13N-NH3) intravenously and undergo a stress digital PET/CT scan of \~20 minute duration~Total patient time will take approximately up to 120 minutes."

DRUG

N-13 ammonia

5-10 mCi intravenous injection of N-13 ammonia radiopharmaceutical at rest and at stress

DRUG

Regadenoson

0.4 mg/5mL intravenous injection to induce pharmacologic stress (Astellas Pharma US, Inc.)

Trial Locations (1)

94305

Stanford University, Stanford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Stanford University

OTHER